“Tocilizumab-Induced Limbic Encephalitis: Another Adverse Effect of Disrupted IL-6 Signalling?”. Archives of Clinical and Medical Case Reports 5, no. 5 (October 21, 2021): 704–709. Accessed September 11, 2026. https://fortunejournals.org/ojs/index.php/acmcr/article/view/22542.